WO2008068393A1 - Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses - Google Patents
Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses Download PDFInfo
- Publication number
- WO2008068393A1 WO2008068393A1 PCT/FR2006/002683 FR2006002683W WO2008068393A1 WO 2008068393 A1 WO2008068393 A1 WO 2008068393A1 FR 2006002683 W FR2006002683 W FR 2006002683W WO 2008068393 A1 WO2008068393 A1 WO 2008068393A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- homeopathic
- herpes
- strain
- insulinum
- dilutions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Definitions
- the present invention relates to the novel use of a homeopathic strain in high dilutions for the preparation of homeopathic medicinal products, alone or in combination, and its method of preparation, these having an active action on Herpesviridae, on papillomaviruses, and on Retroviridae of the RNA type
- Homeopathic preparations that contain it alone or in combination are in the form of granules, doses, ampoules, drops, suppositories, ointment, eye drops, nasal spray or pharyngeal, to be taken by oral, injectable, rectal, cutaneous, ocular or nasal route. and are intended to treat cutaneous, especially labial and genital herpes, cutaneous zoster, in particular ophthalmic, warts, and diseases caused by retroviruses of the RNA type, in particular due to HIV.
- the homeopathic strain to characterize the invention is insulinum, setting high homeopathic dilutions confers and show in the homeopathic medicines prepared therewith, alone or associated antiviral properties against Herpesviridae, on papillomaviruses, and on Retroviridae, these viruses have in common certain characters, they are DNA viruses and as such they are sensitive to insulinum in high homeopathic dilutions which, in homeopathic medicines prepared with it, disrupts the metabolism of the viral DNA. All encode a viral DNA polymerase, an insulin target in high homeopathic dilutions.
- the anti-viral activity of insulinum for characterizing the invention is obtained by its high homeopathic dilutions, made using, for example, the following procedure.
- the procedure according to the invention is constituted by successive Korsakovian dilutions of insulinum with specific energizations on a fossilized stone every 1000 to 10 000 energizations, in one and the same bottle, the contents of which and -even serve in the end impregnation of granules, doses, ampoules, drops, suppositories, sterile solutions, nasal spray or pharyngeal, eye drops and ointments.
- Insulinum in 1000000 K in the non-limiting form of homeopathic granules Dosage and duration of the treatment to be adapted according to the viral load objectified by the blood tests of the T4 lymphocytes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
UTILISATION NOUVELLE D'UNE SOUCHE HOMEOPATHIQUE D' INSULINUM POUR LA PREPARATION DE MEDICAMENTS HOMEOPATHIQUES, ACTIF SUR L'HERPES, LE ZONA, LES VERRUES ET SUR LES VIRUS DE TYPE RNANOVEL USE OF A HOMEOPATHIC INSULINUM STRAIN FOR THE PREPARATION OF HOMEOPATHIC DRUGS, ACTIVE ON HERPES, ZONA, GLANDS AND ON RNA-TYPE VIRUSES
La présente invention concerne la nouvelle utilisation d'une souche homéopathique en hautes dilutions pour la préparation de médicaments homéopathiques, seule ou associée, et son mode de préparation, ceux-ci ayant une action active sur les Herpesviridae, sur les papillomavirus , et sur les Retroviridae de type ARNThe present invention relates to the novel use of a homeopathic strain in high dilutions for the preparation of homeopathic medicinal products, alone or in combination, and its method of preparation, these having an active action on Herpesviridae, on papillomaviruses, and on Retroviridae of the RNA type
Les préparations homéopathiques qui la contiennent seule ou associée se présentent sous forme de granules, doses, ampoules, gouttes, suppositoires, pommade, collyre, spray nasal ou pharyngé, pour être pris par la voie orale, injectable, rectale, cutanée, oculaire ou nasale et sont destinées à traiter l'herpès cutané, notamment labial et génital, le zona cutané, notamment ophtalmique, les verrues, et les affections dues aux rétrovirus de type RNA notamment dues à l' HIV.Homeopathic preparations that contain it alone or in combination are in the form of granules, doses, ampoules, drops, suppositories, ointment, eye drops, nasal spray or pharyngeal, to be taken by oral, injectable, rectal, cutaneous, ocular or nasal route. and are intended to treat cutaneous, especially labial and genital herpes, cutaneous zoster, in particular ophthalmic, warts, and diseases caused by retroviruses of the RNA type, in particular due to HIV.
Les propriétés particulières nouvelles de cette souche homéopathique dans les médicaments homéopathiques préparées avec celle-ci seule ou associée , apparaissent suite à la montée en hautes dilutions selon un protocole opératoire de fabrication original qui lui confère un haut pouvoir de soin sans effet secondaire sur les affections liées au virus de l'herpès, à celui du zona, et à ceux des verrues, et un pouvoir neutralisant et inhibiteur sur le HTV .The particular novel properties of this homeopathic strain in homeopathic medicines prepared with it alone or in combination, appear following the rise in high dilutions according to an original manufacturing protocol which gives it a high level of care with no side effect on the affections herpes, herpes zoster, and warts, and a neutralizing and inhibitory effect on HTV.
La souche homéopathique, pour caractériser Finvention est insulinum, la mise en hautes dilutions homéopathiques lui confère et font apparaître dans les médicaments homéopathiques préparés avec celle-ci, seule ou associée des propriétés antivirales contre les Herpesviridae, sur les papillomavirus , et sur les Retroviridae, ces virus ont en commun certains caractères, ce sont des virus à DNA et à ce titre ils sont sensibles à insulinum en hautes dilutions homéopathiques qui, dans les médicaments homéopathiques préparés avec celle-ci, perturbe le métabolisme du DNA viral. Tous codent pour une DNA polymérase virale, cible d'insulinum en hautes dilutions homéopathiques.The homeopathic strain, to characterize the invention is insulinum, setting high homeopathic dilutions confers and show in the homeopathic medicines prepared therewith, alone or associated antiviral properties against Herpesviridae, on papillomaviruses, and on Retroviridae, these viruses have in common certain characters, they are DNA viruses and as such they are sensitive to insulinum in high homeopathic dilutions which, in homeopathic medicines prepared with it, disrupts the metabolism of the viral DNA. All encode a viral DNA polymerase, an insulin target in high homeopathic dilutions.
Son mode opératoire de fabrication non limitatif est basé, par exemple poux illustrer l'invention, sur la méthode dite Korsakovienne, et ses hautes dilutions non limitatives pour illustrer l'invention seront comprises entre i K et 1 ooo ooo kIts non-limiting manufacturing procedure is based, for example, on the invention of the so-called Korsakovian method, and its high non-limiting dilutions for illustrating the invention will range from 1 K to 1,000,000.
L' activité anti-virale d'insulinum pour caractériser l'invention est obtenue par ses hautes dilutions homéopathiques, réalisées en utilisant par exemple le mode opératoire suivant. Le mode opératoire, selon l'invention, est constitué par des dilutions successives, dites Korsakoviennes, d'insulinum avec des énergisations spécifiques sur une pierre fossilisée toutes les 1000 à 10 ooo dynamisations, dans un même et unique flacon, dont le contenu et lui-même servent en finalité à l'imprégnation des granules, doses, ampoules, gouttes , suppositoires, solutions stériles, spray nasal ou pharyngé, collyres et pommades. A titre d'illustration de l'invention on indiquera ci-après des exemples non limitatifs de dosages d'insulinum en hautes dilutions homéopathiques présents dans des préparations de médicaments homéopathiques sous une forme non limitative , seule ou associée, et ses posologies dans l' utilisation conforme à l'invention, notons que dans le mode opératoire de sa fabrication, le principe de la méthode korsakovienne et ses dilutions en K ou korsakoviennes est non limitatif et pourra être substituée par celle dite hanemanienne et ses dilutions en CH ou centésimales .The anti-viral activity of insulinum for characterizing the invention is obtained by its high homeopathic dilutions, made using, for example, the following procedure. The procedure according to the invention is constituted by successive Korsakovian dilutions of insulinum with specific energizations on a fossilized stone every 1000 to 10 000 energizations, in one and the same bottle, the contents of which and -even serve in the end impregnation of granules, doses, ampoules, drops, suppositories, sterile solutions, nasal spray or pharyngeal, eye drops and ointments. As an illustration of the invention will be given hereinafter non-limiting examples of insulinum assays in high homeopathic dilutions present in homeopathic drug preparations in a non-limiting form, alone or in combination, and its dosages in the use according to the invention, note that in the procedure of its manufacture, the principle of the korsakovian method and its K or korsakovian dilutions is non-limiting and may be substituted by the so-called Hanemanian and its dilutions in CH or centesimal.
Exemple non limitatif de la présentation d'un médicament homéopathique sous forme de granules contenant insulinum avec ses indications spécifiques, son dosage, sa composition et sa posologieNon-limiting example of the presentation of a homeopathic medicine in the form of insulin-containing granules with its specific indications, dosage, composition and dosage
- ZONA Cutané- ZONA Cutaneous
Insulinum en 50000 K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue toutes les 2 heures pendant 10 jours puis 3 à 4 fois par jour pendant 15 joursInsulinum in 50000 K in the non-limiting form of homeopathic granules 3 granules to let melt under the tongue every 2 hours for 10 days then 3 to 4 times a day for 15 days
- ZONA Ophtalmique- Ophthalmic ZONA
Insulinum en 100000 K sous la forme non limitative de granules homéopathiques 5 granules à laisser fondre sous la langue toutes les 2 heures pendant 10 jours puis 3 fois par jour pendant 15 joursInsulinum in 100000 K in the non-limiting form of homeopathic granules 5 granules to let melt under the tongue every 2 hours for 10 days then 3 times a day for 15 days
- HERPES Labial ou Bouton de Fièvre- HERPES Labial or Fever Button
Insulinum en 50000 K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue toutes les 3 heures pendant 7 joursInsulinum in 50000 K in the non-limiting form of homeopathic granules 3 granules to let melt under the tongue every 3 hours for 7 days
- HERPES génital- Genital herpes
Insulinum en îαo 000 K sous la forme non limitative de granules homéopathiques 5 granules à laisser fondre sous la langue toutes les 3 heures pendant 15 joursInsulinum in α 000 K in the non-limiting form of homeopathic granules 5 granules to let melt under the tongue every 3 hours for 15 days
- VERRUES- GLASSES
Insulinum en 10000 K sous la forme non limitative de granules homéopathiques 3 granules à laisser fondre sous la langue 3 fois par pendant 1 mois - INFECTIONS àRETROVERUSInsulinum in 10000 K in the non-limiting form of homeopathic granules 3 granules to let melt under the tongue 3 times for 1 month - INFECTIONS àRETROVERUS
Insulinum en 1000000 K sous la forme non limitative de granules homéopathiques Posologie et durée du traitement à adapter selon la charge virale objectivée parles dosages sanguins des lymphocytes T4 Insulinum in 1000000 K in the non-limiting form of homeopathic granules Dosage and duration of the treatment to be adapted according to the viral load objectified by the blood tests of the T4 lymphocytes
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR2006/002683 WO2008068393A1 (en) | 2006-12-08 | 2006-12-08 | Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/FR2006/002683 WO2008068393A1 (en) | 2006-12-08 | 2006-12-08 | Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2008068393A1 true WO2008068393A1 (en) | 2008-06-12 |
Family
ID=38013625
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/FR2006/002683 Ceased WO2008068393A1 (en) | 2006-12-08 | 2006-12-08 | Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008068393A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6024734A (en) * | 1994-03-31 | 2000-02-15 | Brewitt; Barbara A. | Treatment methods using homeopathic preparations of growth factors |
| US20030191061A1 (en) * | 1994-03-31 | 2003-10-09 | Brewitt Barbara A. | Treatment methods using homeopathic preparations of growth factors |
-
2006
- 2006-12-08 WO PCT/FR2006/002683 patent/WO2008068393A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6024734A (en) * | 1994-03-31 | 2000-02-15 | Brewitt; Barbara A. | Treatment methods using homeopathic preparations of growth factors |
| US20030191061A1 (en) * | 1994-03-31 | 2003-10-09 | Brewitt Barbara A. | Treatment methods using homeopathic preparations of growth factors |
Non-Patent Citations (4)
| Title |
|---|
| BECKER Y ET AL: "INSULIN INHIBITS CELLULAR AND HERPES SIMPLEX VIRUS DNA SYNTHESIS IN TRANSFORMED LYMPHO BLASTOID CELL LINES", INTERVIROLOGY, XX, XX, vol. 10, no. 6, 1978, pages 345 - 350, XP009061931, ISSN: 0300-5526 * |
| BOERICKE W: "HOMOEOPATHIC MATERIA MEDICA", INTERNET CITATION, 17 February 2005 (2005-02-17), XP002368026, Retrieved from the Internet <URL:http://www.homeoint.org/books/boericmm/i/ins.htm> [retrieved on 20060216] * |
| SMITH M A ET AL: "IS SUBCUTANEOUS INJECTION OF INSULIN A VALID TREATMENT FOR HERPES LABIALIS?", JOURNAL OF DENTAL RESEARCH, INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH, US, vol. 68, no. SPEC ISSUE, 1989, pages 414, XP009061930, ISSN: 0022-0345 * |
| SMITH M A ET AL: "SYNERGISTIC ACTIVITY OF INSULIN AND ZINC AGAINST HERPES SIMPLEX VIRUS", JOURNAL OF DENTAL RESEARCH, INTERNATIONAL ASSOCIATION FOR DENTAL RESEARCH, US, vol. 68, no. SPEC ISSUE, 1989, pages 918, XP009061929, ISSN: 0022-0345 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kumar et al. | Druggable targets of SARS-CoV-2 and treatment opportunities for COVID-19 | |
| JP5699135B2 (en) | Drugs for preventing and treating highly pathogenic infections | |
| US6410570B1 (en) | Methods of inactivating a virus and controlling viral replication | |
| Mustafa et al. | Herpes simplex virus infections, Pathophysiology and Management | |
| Vitiello et al. | COVID-19 pandemic: vaccine and new monoclonal antibodies, point of view | |
| US6407125B1 (en) | Pharmacological agent and method of treatment | |
| Cena-Diez et al. | G1-S4 or G2-S16 carbosilane dendrimer in combination with Platycodin D as a promising vaginal microbicide candidate with contraceptive activity | |
| WO2021211659A3 (en) | Treatment for diseases caused by rna viruses | |
| SG170825A1 (en) | Phosponate nucleosides useful as active ingredients in pharmaceutical compositions for the treatment of viral infections, and intermediates for their production | |
| WO2008068393A1 (en) | Novel use of a homeopathic strain of insulinum for preparing homeopathic medicaments, active on herpes, herpes zoster and warts and on rna viruses | |
| Saral et al. | Detection of Molluscum contagiosum virus (MCV) subtype I as a single dominant virus subtype in Molluscum lesions from a Turkish population | |
| FR2887151A1 (en) | Use of a homeopathic insulinum stock (I) to prepare homeopathic medicaments to treat viral infections due to herpes virus, papilloma virus and retrovirus | |
| US20140011839A1 (en) | Compositions and methods for treating and inhibiting viral infections | |
| Curi et al. | Efficacy of imidazolquinoline on treatment of condyloma acuminatum of the buccal mucosa | |
| US20170296530A1 (en) | Compositions and Methods for Treating and Inhibiting Viral Infections | |
| US20040191311A1 (en) | Use of methyltestosterone as a drug for treatment of human papilloma virus infections | |
| US9084758B2 (en) | Antiviral compositions comprising ethanol extract of Tetracera scandens and use thereof | |
| WO2010133652A1 (en) | Multimodal activity of g-quartet oligonucleotides and microbicide compositions | |
| Nadaroglu | Antiviral drugs and plasma therapy used for Covid-19 treatment: a nationwide Turkish algorithm | |
| Khalil et al. | Povidone Iodine (PVP-I) mouth gargle/nasal spray may be the simplest and cost effective therapeutic antidote for COVID-19 Frontier | |
| CN114762694A (en) | Use of oligosaccharyl transferase inhibitors for the prevention and/or treatment of novel coronavirus infections | |
| RU2221562C1 (en) | Medicinal agent and method for treatment of genital pointed condylomatosis | |
| Yadav et al. | to 2025 Update: A Comprehensive Review on Its Complications, Transmission, Diagnosis, and Treatment | |
| WO2013120414A1 (en) | Hiv microbicide and use thereof | |
| Steinmeyer | Open questions about povidone–iodine based preventive measures. Comment to Martínez Lamas et al |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 06841890 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 06841890 Country of ref document: EP Kind code of ref document: A1 |